• Proteolytic Neuroligin 1 Fragments Sustain Social Memory via

  2026-04-20

  Liu et al. uncover a mechanism where social interaction triggers proteolytic cleavage of Neuroligin 1 in the ventral hippocampus, producing an intracellular fragment critical for maintaining social memory. This work links synaptic remodeling to memory retention and provides new insight into molecular substrates of social cognition.

• Sequencing Therapies in Waldenström Macroglobulinemia: Genom

  2026-04-20

  This article examines how genomic profiling, particularly MYD88 and CXCR4 mutation status, informs sequencing of therapies in Waldenström macroglobulinemia (WM). Recent evidence highlights the evolving role of CXCR4 antagonists and combinatorial regimens, with practical implications for translational research and clinical decision-making.

• U-73122 in Cancer Invasion Research: Mechanisms and Beyond

  2026-04-19

  Explore the advanced role of U-73122 as a phospholipase C inhibitor in apoptosis and inflammation research. This article delivers unique molecular insights and practical guidance for PLC signaling pathway modulation, setting it apart from standard protocol-focused resources.

• Cy7 NHS Ester: Protocols and QC for Near-Infrared Protein La

  2026-04-18

  Cy7 NHS ester addresses the challenges of labeling delicate proteins with a hydrophilic, sulfonated near-infrared dye that minimizes aggregation and quenching. It is best used for in vitro and in vivo bioimaging applications requiring high water solubility and minimal protein denaturation. It is not suitable for workflows that require long-term dye solution storage or involve proteins incompatible with NHS ester chemistry.

• Golgi-Tracker Green: Precision Live-Cell Golgi Apparatus Lab

  2026-04-17

  Golgi-Tracker Green, powered by BODIPY FL-labeled C5-ceramide chemistry, delivers unmatched specificity and photostability for live-cell Golgi apparatus imaging. This probe redefines lipid transport and sphingolipid metabolism studies, offering streamlined workflows and robust troubleshooting for translational and mechanistic research.

• 7ACC2: Precision Monocarboxylate Transporter 1 Inhibitor App

  2026-04-16

  7ACC2 stands out as a dual-action monocarboxylate transporter 1 inhibitor, enabling robust dissection of lactate and pyruvate flux in cancer metabolism research. This guide delivers workflow-enhancing tips, troubleshooting insights, and a translational perspective on integrating 7ACC2 into immunometabolic assays.

• ML133 HCl: Selective Kir2.1 Potassium Channel Inhibitor in R

  2026-04-15

  ML133 HCl is a selective potassium channel inhibitor with high specificity for Kir2.1 channels, enabling precise modulation of potassium ion transport in cardiovascular research. It exhibits robust inhibition at low micromolar concentrations and negligible off-target effects on related channels, supporting its use in studies of pulmonary artery smooth muscle cell proliferation.

• DMG-PEG2000-NH2: Mechanistic Insights and Optimization in Li

  2026-04-14

  Explore DMG-PEG2000-NH2 as a high-performance NH2-PEG derivative for precise amide bond formation in lipid nanoparticle and liposomal drug delivery. This article offers a uniquely mechanistic and protocol-driven perspective, grounded in recent research, for optimizing advanced bioconjugation workflows.

• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial A

  2026-04-13

  Temafloxacin is a potent fluoroquinolone broad-spectrum antibacterial agent that disrupts bacterial DNA replication by inhibiting DNA gyrase and topoisomerase IV. Its activity encompasses both Gram-positive and Gram-negative pathogens, making it valuable for research on respiratory and intracellular infections. Evidence from in vitro and in vivo studies supports its efficacy and informs optimal research protocols.

• YC-1: Practical Guide for Cancer and Hypoxia Research Workfl

  2026-04-12

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is a small molecule designed for inhibiting HIF-1α transcriptional activity and activating soluble guanylyl cyclase, addressing experimental needs in tumor angiogenesis inhibition and hypoxia signaling studies. It is not suitable for diagnostic or clinical applications, and solution stability considerations limit its use in long-term studies.

• Troglitazone: New Insights for SPP1-Targeted TAM Modulation

  2026-04-12

  Explore Troglitazone as a selective PPARγ agonist in modulating SPP1-expressing tumor-associated macrophages (TAMs) for advanced type 2 diabetes and oncology research. This article unveils assay-critical nuances and practical guidance not covered elsewhere.

• Ciprofloxacin in Antimicrobial Resistance Research Workflows

  2026-04-11

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, is vital for dissecting bacterial DNA replication inhibition and resistance gene dynamics. This article translates advanced reference data and real-world lab experience into practical protocols, assay enhancements, and troubleshooting guidance for deploying high-purity Ciprofloxacin from APExBIO in cutting-edge antimicrobial resistance research.

• Fulvestrant (ICI 182,780): Applied Workflows in Breast Cance

  2026-04-11

  Fulvestrant (ICI 182,780) stands out as a benchmark tool for dissecting estrogen receptor signaling and overcoming resistance in advanced breast cancer models. This article delivers stepwise experimental guidance, troubleshooting know-how, and practical cross-links to immune- and chemotherapy-sensitization research, anchored by robust literature and the APExBIO product specification.

• Forskolin as a Translational Catalyst: Mechanistic Insigh...

  2026-04-10

  This in-depth thought-leadership article examines Forskolin’s role as a direct adenylate cyclase type I agonist and cAMP signaling modulator, synthesizing mechanistic data, experimental validation, and translational opportunity. Drawing on new models for viral latency and stem cell differentiation, we provide actionable guidance for researchers leveraging Forskolin—such as APExBIO’s Forskolin (B1421)—to accelerate discovery in inflammation, neuronal biology, regenerative medicine, and beyond.

• Scenario-Driven Best Practices for Reliable BMP Pathway M...

  2026-04-09

  This article provides evidence-based guidance for optimizing BMP pathway research using LDN-193189 (SKU A8324). Drawing on real laboratory scenarios, it details validated experimental strategies, protocol optimization, and vendor reliability for cell viability, proliferation, and epithelial barrier assays. Readers will gain actionable insights into reproducibility, selectivity, and workflow efficiency with LDN-193189, grounded in peer-reviewed data and practical experience.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page